All stock lists
Unlock the score
Filana Therapeutics, Inc. (NASDAQ:FLNA)
US · Delayed Price · Currency is USD
Also listed: SAVAHealthcare · Biotechnology
0.61-0.03 (-4.08%)
Insider Score
/ 100
FLNA Insider Score
FILANA THERAPEUTICS, INC. has a live Insider Score.
Scored on 3 qualifying trades from 1 insider in the last 90 days.
FLNA Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 300.00 K | 243.00 K | 367.00 K | 0.00 | 0.00 | 0.00 |
| Gross Profit | -300.00 K | -243.00 K | -367.00 K | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 5.79 M | 6.38 M | 9.33 M | 7.91 M | 40.28 M | 10.92 M |
| R&D Expense | 3.30 M | 4.54 M | 3.85 M | 3.96 M | 5.12 M | 13.67 M |
| Operating Expenses | 9.09 M | 10.93 M | 13.19 M | 11.86 M | 45.39 M | 24.59 M |
| Operating Income | -9.39 M | -11.17 M | -13.55 M | -11.86 M | -45.39 M | -24.59 M |
| Pretax Income | -8.60 M | -10.33 M | -12.54 M | -10.81 M | -44.22 M | -23.40 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -8.60 M | -10.33 M | -12.54 M | -10.81 M | -44.22 M | -23.40 M |
| EPS (Basic) | -0.18 | -0.21 | -0.26 | -0.22 | -0.92 | -0.48 |
| EPS (Diluted) | -0.18 | -0.21 | -0.26 | -0.22 | -0.92 | -0.48 |
| Shares Outstanding | 48.31 M | 48.31 M | 48.31 M | 48.31 M | 48.31 M | 48.26 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.